Coronavirus puts drug repurposing on the fast track

@article{Harrison2020CoronavirusPD,
  title={Coronavirus puts drug repurposing on the fast track},
  author={Charlotte Harrison},
  journal={Nature Biotechnology},
  year={2020},
  volume={38},
  pages={379 - 381}
}
  • C. Harrison
  • Published 27 February 2020
  • Medicine
  • Nature Biotechnology
Existing antivirals and knowledge gained from the SARS and MERS outbreaks gain traction as the fastest route to fight the current coronavirus epidemic. Existing antivirals and knowledge gained from the SARS and MERS outbreaks gain traction as the fastest route to fight the current coronavirus epidemic. 

COVID-19 therapies and vaccine landscape

Within a few weeks of the novel coronavirus genome sequence being published, numerous therapies and vaccines have entered clinical trials with a few showing great promise in alleviating symptoms and

Insight into COVID-19's epidemiology, pathology, and treatment

Drug repurposing in the era of COVID‐19: a call for leadership and government investment

The current COVID19 epidemic suggests that urgent investment in repurposed drugs is a necessary strategy and advises against using standard care for people with viral illnesses.

Immune response and possible therapeutics in COVID-19

This review aims at presenting the available information on the coronavirus disease 2019 along with various drugs that are having widespread use until a vaccine candidate is available to aid in the development of therapeutic strategies against COVID-19.

An update on emerging therapeutics to combat COVID‐19

The CO VID‐19 pandemic has demanded effective therapeutic protocol from researchers and clinicians across the world; the clinician needs objective evidence‐based medication to treat COVID‐19.

The race against COVID-19

  • Biology
    Nature Nanotechnology
  • 2020
The identification and isolation of individuals with COVID-19 can help to flatten the epidemic curve and win us time to wait for the vaccine development and production, and antiviral drug therapies.

Repurposing anticancer drugs for the management of COVID-19

COVID-19: molecular targets, drug repurposing and new avenues for drug discovery

A critical view of ongoing drug repurposing efforts for COVID-19 is presented as well as discussing opportunities for development of new treatments based on current knowledge of the mechanism of infection and potential targets within.
...